| Rafael Martinez, | |
|
1101 26th St S, Great Falls, MT 59405 | |
| (406) 731-8888 | |
| (406) 731-8876 |
| Full Name | Rafael Martinez |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 10 Years |
| Location | 1101 26th St S, Great Falls, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508286451 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 04558 (Kentucky) | Secondary |
| 208M00000X | Hospitalist | 52575 (Montana) | Secondary |
| 207Q00000X | Family Medicine | 52575 (Montana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Twin Lakes Regional Medical Center | Leitchfield, KY | Hospital |
| Great Falls Clinic Hospital | Great falls, MT | Hospital |
| Baptist Emergency Hospital | San antonio, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cmsc Llc | 5890602494 | 25 |
| Concord Company Of Tennessee Pllc | 0345588109 | 17 |
| Third Coast Emergency Physicians Southwest Pa | 6800794447 | 44 |
News Archive
Results from a phase 3 clinical trial indicate that patients who have not benefited from standard therapy for ankylosing spondylitis, a chronic inflammatory disease characterized by back pain and sacroiliac-joint damage, may have another treatment option in the biologic drug ixekizumab.
Among patients undergoing spinal surgery, Medicaid beneficiaries are at higher risk of experiencing any type of complication, compared to privately insured patients, reports a study in the July 15 issue of of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Tumours with undetectable levels of the copper transporter CTR1 have a significantly reduced response to platinum-based chemotherapy for non-small-cell lung cancer, study findings indicate.
Syngenta announced today that it plans to construct a new state-of-the-art biotechnology research facility adjacent to its existing research campus in Research Triangle Park, North Carolina. The $71 million investment, which is scheduled to begin in June 2011, will focus on discovering and developing new agronomic traits to bring innovative solutions to growers across the world.
› Verified 2 days ago
| Entity Name | Benefis Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780968974 PECOS PAC ID: 1153235296 Enrollment ID: O20100629000044 |
News Archive
Results from a phase 3 clinical trial indicate that patients who have not benefited from standard therapy for ankylosing spondylitis, a chronic inflammatory disease characterized by back pain and sacroiliac-joint damage, may have another treatment option in the biologic drug ixekizumab.
Among patients undergoing spinal surgery, Medicaid beneficiaries are at higher risk of experiencing any type of complication, compared to privately insured patients, reports a study in the July 15 issue of of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Tumours with undetectable levels of the copper transporter CTR1 have a significantly reduced response to platinum-based chemotherapy for non-small-cell lung cancer, study findings indicate.
Syngenta announced today that it plans to construct a new state-of-the-art biotechnology research facility adjacent to its existing research campus in Research Triangle Park, North Carolina. The $71 million investment, which is scheduled to begin in June 2011, will focus on discovering and developing new agronomic traits to bring innovative solutions to growers across the world.
› Verified 2 days ago
| Entity Name | Cmsc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639109978 PECOS PAC ID: 5890602494 Enrollment ID: O20130502000527 |
News Archive
Results from a phase 3 clinical trial indicate that patients who have not benefited from standard therapy for ankylosing spondylitis, a chronic inflammatory disease characterized by back pain and sacroiliac-joint damage, may have another treatment option in the biologic drug ixekizumab.
Among patients undergoing spinal surgery, Medicaid beneficiaries are at higher risk of experiencing any type of complication, compared to privately insured patients, reports a study in the July 15 issue of of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Tumours with undetectable levels of the copper transporter CTR1 have a significantly reduced response to platinum-based chemotherapy for non-small-cell lung cancer, study findings indicate.
Syngenta announced today that it plans to construct a new state-of-the-art biotechnology research facility adjacent to its existing research campus in Research Triangle Park, North Carolina. The $71 million investment, which is scheduled to begin in June 2011, will focus on discovering and developing new agronomic traits to bring innovative solutions to growers across the world.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rafael Martinez, 1101 26th St S, Great Falls, MT 59405 Ph: (406) 731-8888 | Rafael Martinez, 1101 26th St S, Great Falls, MT 59405 Ph: (406) 731-8888 |
News Archive
Results from a phase 3 clinical trial indicate that patients who have not benefited from standard therapy for ankylosing spondylitis, a chronic inflammatory disease characterized by back pain and sacroiliac-joint damage, may have another treatment option in the biologic drug ixekizumab.
Among patients undergoing spinal surgery, Medicaid beneficiaries are at higher risk of experiencing any type of complication, compared to privately insured patients, reports a study in the July 15 issue of of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Tumours with undetectable levels of the copper transporter CTR1 have a significantly reduced response to platinum-based chemotherapy for non-small-cell lung cancer, study findings indicate.
Syngenta announced today that it plans to construct a new state-of-the-art biotechnology research facility adjacent to its existing research campus in Research Triangle Park, North Carolina. The $71 million investment, which is scheduled to begin in June 2011, will focus on discovering and developing new agronomic traits to bring innovative solutions to growers across the world.
› Verified 2 days ago
James H Asthalter, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1400 29th St S, Great Falls, MT 59405 Phone: 406-454-2171 Fax: 406-771-3021 | |
Dr. Margaret Anne Becker, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 115 4th St S, Great Falls, MT 59401 Phone: 406-453-1634 | |
Carey J Welsh, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Division Rd, Great Falls, MT 59404 Phone: 406-268-1600 Fax: 406-771-3549 | |
Mr. Marcus A. Johnson, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2201 Sun River Rd, Great Falls, MT 59404 Phone: 406-452-9927 | |
Mr. Christopher Gleason, MSN APRN FNP-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1400 29th St S Ste 1, Great Falls, MT 59405 Phone: 406-454-6973 | |
David R Engbrecht, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 Division Rd, Great Falls, MT 59404 Phone: 406-268-1600 Fax: 406-771-3549 | |
Loy L Anderson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1600 Division Road, Great Falls, MT 59404 Phone: 406-268-1600 Fax: 406-771-3549 |